. 2008 Sep 4;38(10):661–669. doi: 10.1093/jjco/hyn089

Table 3.

Disease-free and overall survival of the patients according to various characteristics^a

Characteristics	Number of patients	5-year disease-free survival (%)	P value^b	5-year overall survival (%)	P value^b
Gender
Female	45	42	0.623	55	0.327
Male	153	36	0.623	44	0.327
Age
≤63^c	111	38	0.875	47	0.648
>63	87	36	0.875	46	0.648
History of smoking
Yes	158	34	0.230	43	0.080
No	40	50	0.230	59	0.080
Operation
Lobectomy^d	138	37	0.419	49	0.063
Pneumonectomy	60	37	0.419	42	0.063
Histologic type
Squamous	90	40	0.687	46	0.746
Non-squamous	108	35	0.687	46	0.746
Tumor size (cm)
≤3.9^e	103	44	0.019	52	0.026
>3.9	95	29	0.019	41	0.026
Stage^f
I	95	51	<0.0001	59	<0.0001
II	45	33		44
IIIA	44	20		29
IIIB	14	7		21
Resection margin
Negative	181	38	0.155	49	0.037
Positive	17	24	0.155	24	0.037
Expression of Bax
Low	151	35	0.381^g	45	0.247^h
High	47	45	0.381^g	53	0.247^h
Expression of p53
Low	121	38	0.579	48	0.566
High	77	36	0.579	44	0.566
Expression of galectin-3
Low	96	34	0.237	42	0.157
High	102	40	0.237	50	0.157

^aExcluding seven patients who died of post-operative complication. ^bLog-rank test. ^cMedian age. ^dIncluding wedge resection. ^eMedian longest diameter of primary tumor. ^fPost-operative pathologic staging. ^gP = 0.103 according to the Wilcoxon test. ^hP = 0.057 according to the Wilcoxon test.